mProX™ Human SLC22A8 Stable Cell Line
- Product Category:
- Membrane Protein Stable Cell Lines
- Subcategory:
- Transporter Cell Lines
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number
Made to Order Inquiry
InquiryBased on this stable cell line, we also provide cell-based in vitro assays to evaluate the effects of your compounds or antibodies.
Product Information
Product Properties
Protocols
Please visit our protocols page.
Customer Reviews
Matthew
Verified Customer
Kevin
Verified Customer
Any questions about our products? Please visit our frequently asked questions page.
Published Data
Fig.1 Expression of SLC22A8 (OAT3) and it´s allelic variants in HEK293T cells line.
Elevated magnification of allelic variant R149C: HEK293T cells line expresses SLC22A8 (OAT3) and its allelic variations. Using polyethyleneimine lipofection, cells were transiently transfected with wild type protein that had been tagged with a C-terminal GFP tag.
Ref: Vávra, Jiří, et al. "Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort." Cells 11.7 (2022): 1063.
Pubmed: 35406626
DOI: 10.3390/cells11071063
Research Highlights
The idea that OAT1 is more significant in kidney proximal tubule metabolism and OAT3 is more significant in systemic metabolism-regulating the amounts of metabolites passing through the colon, liver, and kidney-is supported by metabolomics and pathway analysis.
Bush, Kevin T., et al. "The drug transporter OAT3 (SLC22A8) and endogenous metabolite communication via the gut-liver-kidney axis." Journal of Biological Chemistry 292.38 (2017): 15789-15803.
Pubmed:
28765282
DOI:
10.1074/jbc.M117.796516
A thorough examination of the tumor microenvironment and tumor immune infiltration revealed a greater degree of general immunity in the SLC22A8 low expression group. The results of the Gene Enrichment Analysis demonstrated a correlation between low expression of SLC22A8 and immunological pathways, including humoral immune response and phagocytosis recognition. SLC22A8 expression can be employed as a predictive biomarker for ccRCC because it was found to be highly linked with both immune infiltration and survival in ccRCC.
Xu, Ke, et al. "SLC22A8: An indicator for tumor immune microenvironment and prognosis of ccRCC from a comprehensive analysis of bioinformatics." Medicine 101.37 (2022).
Pubmed:
36123895
DOI:
10.1097/MD.0000000000030270